Anchiano Therapeutics Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating income was USD 3.897 million compared to USD 2.505 million a year ago. Net loss was USD 15.918 million compared to USD 2.633 million a year ago. For the nine months, operating income was USD 13.774 million compared to USD 10.068 million a year ago. Net loss was USD 36.175 million compared to USD 11.470 million a year ago.